Clinical Update
Parvovirus B19: An opportunistic healthcare burden
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i11.16663Keywords:
Parvovirus B19Abstract
Parvovirus B19 is notoriously a cause of normocytic anaemia in patients in an immunocompromised state, more so than in patients without prior disease. It is increasingly prevalent in children and adults in an HIV-induced immunocompromised state, and its presentation may be varied. Red-cell aplasia and normocytic anaemia are common presenting derangements found. Here, we note the typical presentation of red-cell aplasia re-entering healthcare, with a dire effect on the quality of life of this patient.
References
Sim JY, Chang LY, Chen JM, et al. Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect 2019;52(4):534-541. https://doi.org/10.1016/j. jmii.2019.05.009
Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989;149(5):1153-1156.
Nasir IA, Medugu T, Dangana A. Human parvovirus B19-associated hematopathy in HIV disease: Need for clinicopathological revisit. J Biomed Res 2018;32(1):1-2. https://doi.org/10.7555/JBR.32.2017010 4. Clarke J, Lee JD. Primary human parvovirus B19 infection in an HIV-infected patient on highly active
antiretroviral therapy. Sex Transm Infect 2003;79(4):336. https://doi.org/10.1136/sti.79.4.336
Wilson D. Haematology. In: Maartens G, Cotton M, Wilson D, Venter F, Meyers T, Bekker L (editors). Oxford Handbook of HIV Medicine. Third ed. Johannesburg: Oxford University Press Southern
Africa, 2012:305-306.
LouwS.ParvovirusB19...anopportunist.https://sahivsoc.org/Files/13C%20-%20Susan%20Louw%20
-%20Parvo%20virus%20(PB19).pdf (accessed 17 October 2022).
Southern African HIV Clinicians Society. Guideline for the prevention, diagnosis and management of
cryptococcal disease among HIV-infected persons: 2019 update. sajhivmed. https://sahivsoc.org/Files/
crypto%20guidelines.pdf (accessed 10 January 2022).
Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV Working Group. Anemia in
HIV infection: Clinical impact and evidence-based management strategies. Clin Infect Dis
;38(10):1454-1463. https://doi.org/10.1086/383031
Durandt C, Potgieter JC, Mellet J, et al. HIV and haematopoiesis. S Afr Med J 2019;109( 8b):40-45.
https://doi.org/10.7196/SAMJ.2019.v109i8b.13829
Subbaraman R, Devaleenal B, Selvamuthu P, et al. Factors associated with anaemia in HIV-infected individuals in southern India. Int J STD AIDS 2009;20(7):489-492. https://doi.org/10.1258/ ijsa.2008.008370
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
